tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

EMREmerson Electric

Industrials · Electrical Equipment · NYSE
Compare with peers → Embed
SEC comment letters, last 20 years

2 reviews of EMR's filings by SEC staff

UPLOAD and CORRESP
ReviewsRead ↓
2
latest letter 2017-01-30
Questions asked
4
each answered in the company's own letter
No closing letter
0
reviews without a letter saying the staff completed it

When the SEC's staff reviews a filing, it writes to the company with numbered questions, and the company answers each one in a letter. SEC publishes the exchange once the review is over, at least 20 business days later. A question is not an accusation; most reviews end with the company adding detail to its next filing.

Form 10-K for the Fiscal Year ended September 30, 2016

2017-01-30 to 2017-03-08 · 3 questions · 1 letter from the SEC, 1 from the company
Review closed 2017-03-08
Non-GAAP measures
Exhibit 99.1
SEC asked (1)
We note that you present non-GAAP operating measures which adjust captions from your income statement to include the results that are presented as discontinued operations under ASC 205 in the consolidated financial statements included in your September 30, 2016 Form 10-K. Please tell us why you believe this presentation is meaningful to an investor.
Rest of the question

In addition, please explain to us how you considered the guidance in Question 100.04 in the updated Compliance and Disclosure Interpretations issued on May 17, 2016 related to the use of individually tailored recognition and measurement methods.

EMR answered
In our earnings release filed with the SEC on November 1, 2016 (the “Release”), we presented income statement measures that were adjusted to include results presented as discontinued operations in our consolidated financial statements, as well as to exclude prior year divestiture gains. As stated at the end of the first paragraph of the Release, this was done to facilitate comparisons by investors between our 2016 results and our (i) 2015 results, (ii) results for the first three quarters of 2016, and (iii) 2016 guidance.
Rest of the answer

Please see our response to Comment #2 below for further detail regarding the intent of our presentation method and why we believe the method of presentation was the best way to convey to investors the Company’s results of operations for fiscal 2016.

In addition, please explain to us how you considered the guidance in Question 100.04 in the updated Compliance and Disclosure Interpretations issued on May 17, 2016 related to the use of individually tailored recognition and measurement methods.

We did not interpret Question 100.04 of the updated Compliance and Disclosure Interpretations as being inconsistent with our non-GAAP disclosures in the Release. Question 100.04 indicates that substituting individually tailored recognition and measurement methods in place of GAAP measures when presenting non-GAAP revenue and other financial statement measures may violate Rule 100(b) of Regulation G. We did not do this. No changes or adjustments were made to our recognition or measurement methods in determining the non-GAAP revenue or other financial statement amounts included in the release.

The non-GAAP measures we used in the Release included amounts related to our discontinued operations that would have been aggregated into the comparable GAAP measures, but for the fact that the businesses were being sold. There were no different standards of recognition or measurement used when disaggregating such amounts, adding them to the applicable items of our continuing operations, and presenting the sums of such items as non-GAAP measures in the Release.

In particular, we note that the only revenue adjustment was to add revenues relating to discontinued operations to our GAAP revenue amounts in order to provide a revenue amount that would be comparable to the reported prior year’s, prior three quarters’ and prior guidance, which were in accordance with GAAP and included revenues from our businesses that were subsequently reclassified to discontinued operations. All revenues from those discontinued operations were calculated pursuant to our existing revenue recognition policies which are in accordance with GAAP.

Read in the reply ↗
In its next report

First report after the company's reply of 2017-02-24: 10-Q filed 2017-05-04 ↗, against the 10-Q filed 2016-08-03 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Exhibit 99.1
SEC asked (2)
As a related matter, we note that net sales including sales from discontinued operations is presented in the summary on page 1 more prominently than reported sales from continuing operations. In addition, you discuss Fiscal Year Results on an Adjusted Basis and Fourth Quarter Results on an Adjusted Basis on pages 1 and 3 with greater prominence than the related GAAP reported results.
Rest of the question

These adjusted results appear to be non-GAAP measures although they are not described as such. In future filings please appropriately identify all non-GAAP measures and present the most directly comparable GAAP measure with equal or greater prominence in accordance with Item 10(e)(1)(i)(A) of Regulation S-K and Question 102.10 in the updated Compliance and Disclosure Interpretations issued on May 17, 2016.

EMR answered
We confirm that in future filings we plan to appropriately identify all non-GAAP measures and present the most directly comparable GAAP measure with equal or greater prominence in accordance with Item 10(e)(1)(i)(A) of Regulation S-K and Question 102.10 in the updated Compliance and Disclosure Interpretations issued on May 17, 2016.

We would like to explain to the Staff the reasoning behind our presentation in the Release of various fiscal year and fourth quarter measures on an adjusted (non-GAAP) basis prior to the related GAAP reported results.
Rest of the answer

Presentation of these measures in this order was a one-time effort to facilitate understanding of Emerson’s momentous strategic transition in 2016. Our earnings release reporting results for our first fiscal quarter of 2017, filed with the SEC on February 7, 2017, did not follow this same disclosure format, nor will our future releases, as it is no longer necessary to provide a transition explanation for our shareholders between the historical Emerson and the new Emerson, as described below.

In June 2015 Emerson announced a strategic repositioning effort which included the spinoff or sale of companies comprising approximately 30% of Emerson’s sales. By the end of fiscal 2016 Emerson had entered into agreements to sell those businesses, and the financial results for those businesses were reflected in discontinued operations in Emerson’s 2016 financial statements. As a result, our full year 2016 financial results were not readily comparable to (i) 2015 results, (ii) results for the first three quarters of 2016, and (iii) 2016 guidance.

The presentation method used in the Release was our attempt to help investors better understand the fiscal 2016 results and the impact of the pending divestitures on those results, and to aid in comparisons to prior year results and guidance. We believe that taken as a whole, and given the circumstances impacting

Emerson in fiscal 2016, the sequence of the presentation allowed for the clearest explanation of all of the matters that impacted our fiscal 2016 financial results.

To lead investors through our fiscal 2016 results, we began by discussing adjusted results, as if the businesses included in discontinued operations were not discontinued. This was intended to provide investors with a comparable basis look-back to our prior results and guidance with which they would be familiar. Before investors could understand the Company post-repositioning, we believed they first needed to clearly understand our performance compared to what they knew about the past. We then provided our GAAP results, with the businesses being divested included in discontinued operations, to provide our investors a starting point in evaluating the Company’s future performance. We believed this presentation would be the least confusing way to present a complex situation, and provide the most logical progression of information to our investors.

Addressing your comment that not all our adjusted results in the Release were described as non-GAAP measures, we note that in the first paragraph of the Release we differentiated our non-GAAP “Results on an Adjusted Basis” from our “Reported Results from Continuing Operations” to indicate that information in the Release referred to as “adjusted” was non-GAAP. All such non-GAAP measures were then noted as adjusted, either in section headings or otherwise, and further identified as non-GAAP and reconciled in Table 7 of the Release. In the future, we will clearly indicate any adjusted financial measures we may provide.

Read in the reply ↗
In its next report

First report after the company's reply of 2017-02-24: 10-Q filed 2017-05-04 ↗, against the 10-Q filed 2016-08-03 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Exhibit 99.1
SEC asked (3)
We also reference the amounts in table 7 on page 13 under Adjusted Basis Margins. Please explain to us how the adjusted amounts were determined and where you have included the reconciliation to the most comparable GAAP measures, as required by Regulation G. Please note that all reconciliations should start with the GAAP or reported measure so that investors can see the adjustments that lead to the non-GAAP measure.
EMR answered
As noted in our response to Comment #1, non-GAAP operating measures were presented which adjusted amounts from the GAAP measures by including results of businesses presented in discontinued operations. These same non-GAAP operating measures were used to determine the Adjusted Basis Margins in Table 7.

Please see the items marked with an asterisk (*) under Adjusted Basis Margins in Table 7, which sets forth amounts for (i) adjusted basis gross profit margin, (ii) adjusted basis operating margin, (iii) adjusted basis earnings before interest and taxes margin, and (iv) adjusted basis pretax
Rest of the answer

earnings margin. These margins were calculated by dividing the adjusted basis dollar amounts for each of these measures into adjusted basis sales for the fiscal years and fourth quarters of 2015 and 2016. Adjusted basis sales is reconciled immediately above the Adjusted Basis Margins reconciliation in Table 7.

In column one on page 2 of the Release are references to adjusted basis operating margin of “16.9 percent”, adjusted basis EBIT margin of “14.8 percent” and the adjusted basis pretax earnings margin of “13.9 percent”. Each of these amounts is ultimately reconciled to the comparable GAAP measure in Table 7.

Initially, these adjusted margin measures were reconciled to adjusted basis pretax earnings margin at the bottom of the “Adjusted Basis Margins” portion of Table 7. In addition, since all of the adjusted numbers in the previous paragraph are non-GAAP, the reconciliation in Table 7 continues on to reconcile all these same measures to the comparable continuing operations margins measures under the heading “Continuing Operations Margins” in Table 7.

For example, column one provides the 13.9% adjusted basis pretax earnings margin, and then by removing discontinued operations of 2.1% arrives at 16.0% reported pretax margin from continuing operations, which is a GAAP number. The reported pretax margin measure is also included on page 2 of the Release.

Further, the reconciliation goes on to reconcile this GAAP measure to the non-GAAP continuing operations EBIT and operating profit margins, which are comparable to the adjusted basis margins discussed above, so that all the GAAP and non-GAAP measures can be compared and reconciled.

The Company believes it made a significant effort to provide the reconciliations to the most comparable GAAP measures as required by Regulation G and Item 10 of Regulation S-K in Table 7. As discussed above, this was a challenging communication and the Company believed the Adjusted Basis Margin reconciliation presented in Table 7 was the clearest method of presentation to assist investors in understanding the various measures provided and the adjustments between them as it transitioned to reporting continuing and discontinued operations in accordance with GAAP.

Please note that all reconciliations should start with the GAAP or reported measure so that investors can see the adjustments that lead to the non-GAAP measure.

Response: The Company acknowledges the Staff’s comment that reconciliations should start with the GAAP or reported measure and we confirm that, in future filings, we plan to provide the GAAP or reported measures as the first step in any reconciliation.

Read in the reply ↗
In its next report

First report after the company's reply of 2017-02-24: 10-Q filed 2017-05-04 ↗, against the 10-Q filed 2016-08-03 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Also in this review: closing letter, 2017-03-08

Form 10-K for the Fiscal Year Ended September 30, 2013

2014-01-02 to 2014-01-16 · 1 question · 1 letter from the SEC, 1 from the company
Review closed 2014-01-16
Non-GAAP measuresResults discussion (MD&A)
Operations · Non-GAAP Financial Measures, page 16
SEC asked
We see that you include certain non-GAAP measures as part of Management’s Discussion and Analysis. Please tell us where you provide the required reconciliations of the differences between the non-GAAP financial measures disclosed with the most directly comparable financial measure calculated in accordance with GAAP, otherwise please revise future filings to provide the reconciliations required by Item 10(e)(1)(i)B
Rest of the question

of Regulation S-K.

EMR answered
As noted on page 16 of the Company’s 2013 Form 10-K, Emerson uses certain non-GAAP financial measures, as such term is defined under Item 10 of Regulation S-K. The Company provides a list of the non-GAAP measures most commonly used, the comparable measures under GAAP, and a statement of why management believes the non-GAAP measures are useful to investors and analysts, as required by Item 10.

In Emerson’s 2013 Form 10-K, including portions of its 2013 Annual Report to Shareholders incorporated as Exhibit 13, the Company uses the non-GAAP financial measures underlying sales (comparable GAAP
Rest of the answer

measure, net sales), net earnings and earnings per share excluding impairment and related income tax charges (comparable GAAP measures, net earnings and diluted earnings per share), and free cash flow (comparable GAAP measure, operating cash flow).

The Company’s typical approach is to provide the GAAP measure, the non-GAAP measure, and the necessary quantitative reconciliation all within the applicable business discussion pursuant to Item 10 (“reconciliation by schedule or other clearly understandable method”). The Company believes giving all these elements together, rather than reconciling in a separate table, often provides investors and analysts useful insight into the Company’s operating performance and enhances understanding.

Below are excerpts from the 2013 Form 10-K of the primary non-GAAP measures presented together with the most comparable GAAP measures, in each instance quantifying the items that complete the reconciliation. This same approach is used throughout Management’s Discussion and Analysis in analyzing and reconciling segment and international sales growth. The colored accents, bold and underlines have been added to highlight the GAAP and non-GAAP measures and the reconciling items.

Form 10-K, page 16: Fiscal 2014 Outlook (2014 Underlying Sales and Earnings Per Share)

“Emerson underlying sales are expected to grow 3 to 5 percent in 2014, excluding (4) percent from acquisitions and the previously announced divestiture of the embedded computing and power business. Reported sales are expected to change (1) to 1 percent.”

“Earnings per share are expected to increase 4 to 7 percent excluding an approximate 30 percent impact from impairment and repatriation charges, or increase 33 to 38 percent on a reported basis.”

Form 10-K, Exhibit 13, page 2: Results of Operations - Overview, second paragraph (2013 Net Earnings, 2013 and 2012 Earnings Per Share)

“Net earnings common stockholders were $2.0 billion in 2013, up 2 percent versus prior year. Diluted earnings per share were $2.76, up 3 percent compared with $2.67 per share in 2012. Excluding impairment and income tax charges, 2013 net earnings were $2.6 billion, up 3 percent, while earnings per share were $3.54, up 4 percent compared with $3.39 in 2012. These charges primarily related to the embedded computing and power business, and totaled $566 million ($0.78 per share) in 2013 and $528 million ($0.72 per share) in 2012. See Goodwill Impairment in the discussion that follows and Notes 3 and 6 for additional information.”

Form 10-K, Exhibit 13, page 2: Results of Operations -- Net Sales, first paragraph (2013 Underlying Sales)

“Net sales for 2013 were $24.7 billion, an increase of $257 million, or 1 percent compared with 2012. Consolidated results reflect a 2 percent ($388 million) increase in underlying sales driven by volume gains. Underlying sales exclude foreign currency translation, acquisitions and divestitures. Foreign currency translation ($55 million) and divestitures, net of acquisitions ($76 million) had a combined negative 1 percent impact.”

Form 10-K, Exhibit 13, page 9: Financial Position, Capital Resources and Liquidity, Cash Flow table (Free Cash Flow)

“Cash Flow

(dollars in millions)

2011

2012

2013

Operating Cash Flow

$

3,233

3,053

3,649

Percent of sales

13.3

%

12.5

14.8

Capital Expenditures

647

665

678

2.7

Free Cash Flow (Operating Cash Flow less Capital Expenditures)

2,586

2,388

2,971

10.6

9.8

12.0

%"

We believe the Company’s approach complies with the reconciliation requirements of Item 10(e)(1)(i)B of Regulation S-K and provides investors and analysts clear, concise and transparent insight into the Company’s results of operations.

The Company acknowledges its responsibility for the adequacy and accuracy of the disclosure in the filing; that Staff comments or changes to disclosure in response to Staff comments do not foreclose the Commission from taking any action with respect to the filing; and that the Company may not assert Staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Read in the reply ↗
In its next report

First report after the company's reply of 2014-01-09: 10-Q filed 2014-02-05 ↗.

No earlier 10-Q before the SEC's letter is in Tickdelta, so there is nothing to compare with.

Also in this review: closing letter, 2014-01-16

Other letters

Letters without questions

UPLOAD and CORRESP
2 other letters: notices that a filing will not be reviewed, requests to declare a registration effective, and the like
  • 2025-02-27 · EMR: letter to the SEC · Aspen Technology, Inc. · Schedule TO-T/A / 13E-3/A filed on February 24, 2025 · Filed...
  • 2025-02-24 · EMR: letter to the SEC · Aspen Technology, Inc. · Schedule TO-T / 13E-3 filed on February 10, 2025 · Filed by...

From the SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), 14 letters filed since 2014-01-03. Questions and answers are matched by their numbers; topics come from words in each question. The reports are compared word for word (same form, before the first SEC letter against the first report after the company's reply). No AI.

Next in Owners and insiders Insider trades →